Challenges in IBD Research 2024: Precision Medicine
Inflammatory Bowel Diseases · 23.05.2024 · 30 (Supplement_2) · S39-S54
DOI: 10.1093/ibd/izae084 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 23.05.2024. Verfasst von Sana Syed und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Virginia, Charlottesville, VA, USA. Hauptthemen laut MEDLINE: Precision Medicine, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH.
Abstract (Originalsprache)
Precision medicine is part of 5 focus areas of the Challenges in IBD Research 2024 research document, which also includes preclinical human IBD mechanisms, environmental triggers, novel technologies, and pragmatic clinical research. Building on Challenges in IBD Research 2019, the current Challenges aims to provide a comprehensive overview of current gaps in inflammatory bowel diseases (IBDs) research and deliver actionable approaches to address them with a focus on how these gaps can lead to advancements in interception, remission, and restoration for these diseases. The document is the result of multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient-centric research prioritization. In particular, the precision medicine section is focused on the main research gaps in elucidating how to bring the best care to the individual patient in IBD. Research gaps were identified in biomarker discovery and validation for predicting disease progression and choosing the most appropriate treatment for each patient. Other gaps were identified in making the best use of existing patient biosamples and clinical data, developing new technologies to analyze large datasets, and overcoming regulatory and payer hurdles to enable clinical use of biomarkers. To address these gaps, the Workgroup suggests focusing on thoroughly validating existing candidate biomarkers, using best-in-class data generation and analysis tools, and establishing cross-disciplinary teams to tackle regulatory hurdles as early as possible. Altogether, the precision medicine group recognizes the importance of bringing basic scientific biomarker discovery and translating it into the clinic to help improve the lives of IBD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
- Patient representative for Crohn's & Colitis Foundation, New York, NY, USA.
- Department of Medicine, University of California San Diego, La Jolla, CA, USA.
- Precision Medicine Drug Development, Early Respiratory and Immunology, AstraZeneca, Boston, MA, USA.
- Division of Gastroenterology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
- Leona M. and Harry B. Helmsley Charitable Trust, New York, NY, USA.
ORCID-Profile: Angela Dobes, Benjamin Kostiuk, Joana Torres
Förderung
- NIDDK NIH HHS
- NIH
Zitieren
APA
Syed, S., Boland, B. S., Bourke, L. T., Chen, L. A., Churchill, L., Dobes, A., Greene, A., Heller, C., Jayson, C., Kostiuk, B., Moss, A., Najdawi, F., Plung, L., Rioux, J. D., Rosen, M. J., Torres, J., Zulqarnain, F., & Satsangi, J. (2024). Challenges in IBD Research 2024: Precision Medicine. Inflammatory Bowel Diseases, 30(Supplement_2), S39-S54. https://doi.org/10.1093/ibd/izae084
Vancouver
Syed S, Boland BS, Bourke LT, Chen LA, Churchill L, Dobes A, et al. Challenges in IBD Research 2024: Precision Medicine. Inflammatory Bowel Diseases. 2024;30(Supplement_2):S39-S54. doi:10.1093/ibd/izae084
BibTeX
@article{Syed2024,
author = {Syed, Sana and Boland, Brigid S and Bourke, Lauren T and Chen, Lea Ann and Churchill, Laurie and Dobes, Angela and Greene, Adam and Heller, Caren and Jayson, Christina and Kostiuk, Benjamin and Moss, Alan and Najdawi, Fedaa and Plung, Lori and Rioux, John D and Rosen, Michael J and Torres, Joana and Zulqarnain, Fatima and Satsangi, Jack},
title = {Challenges in IBD Research 2024: Precision Medicine},
journal = {Inflammatory Bowel Diseases},
year = {2024},
volume = {30},
number = {Supplement_2},
pages = {S39--S54},
doi = {10.1093/ibd/izae084}
}
EUVIMED